text: InterMune Gets Subpoena from Justice Dept (Reuters) Reuters - Biotechnology company InterMune Inc. \on Tuesday said it received a subpoena from the U.S. Department\of Justice demanding information related to its key drug\Actimmune, which is designed to spur the immune system.